CompletedNot Applicable

Partial Response to Proton Pump Inhibitors (PPI) Treatment: The Cost to Society and the Burden to the Patient - a Study in the US

United States552 participantsStarted 2008-11

Plain-language summary

The purpose of this study is to describe common treatment pathways, to collect health care utilization data and to assess symptom load as well as impact of symptoms on daily life in GERD patients who are partial-responders to PPI treatment.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * At least 6 month history of GERD symptoms * Treated with unchanged optimized PPI treatment for any GERD indication during a consecutive 4 week period * Remaining GERD symptoms despite optimized PPI treatment * Able to read and write in US English, and able to comply with study requirements Exclusion Criteria: * Patients that have not experienced any GERD symptom improvement at all during PPI treatment * Involvement in the planning or conduct of the study * Involvement in any other observational study or in any clinical study at the time of this study or during the last 6 months

What they're measuring

Quality of life, productivity loss, frequency and severity of GERD symptoms, health care resource use

Timeframe: Collected at enrollment visit and at 3 and 6 month follow-up. (Health care resource use is at enrollment visit collected retrospectively 6 months)

Utility values

Timeframe: Collected at enrollment visit and at 6 month follow-up.

Trial details

NCT IDNCT00795093

SponsorAstraZeneca

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2010-01

View on ClinicalTrials.gov More Gastroesophageal Reflux Disease (GERD) trials